Narrow-moat Sonic’s top line continues to grow at a steady clip, with organic revenue up 6% so far in the second half of fiscal 2024, following 6% growth in the first half. Our fiscal 2024 revenue forecast of AUD 8.9 billion is broadly unchanged and in line with company guidance.
Sonic has a leading market position in most of its geographies and as a result benefits from a cost advantage derived from scale.
Elevated covid-19 testing is not able to be maintained and acquisitive growth is becoming more expensive to achieve.
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.02 | 2.63 | 16.16 |
Price/Book Value | 1.54 | 0.92 | 2.43 |
Price/Sales | 1.41 | 0.48 | 1.71 |
Price/Cash Flow | 10.34 | 2.84 | 11.25 |
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Quick Ratio | 0.78 | 0.44 | 0.78 |
Current Ratio | 0.94 | 0.53 | 0.97 |
Interest Coverage | 5.95 | −13.26 | 7.31 |
|
Metric
|
SHL
|
HLS
|
DGX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.07% | 0.10% | 7.33% |
Return on Equity (Normalized) | 7.01% | 0.23% | 15.76% |
Return on Invested Capital (Normalized) | 4.52% | 2.27% | 9.73% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Lcbwjtztx | Nrxf | $219.8 Bil | |||
| Danaher Corp
DHR
| Xxjvmwcy | Ynjrys | $193.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Lccwzsrlv | Lhdtrr | $42.0 Bil | |||
| IQVIA Holdings Inc
IQV
| Nzsqydc | Dwnqtc | $39.3 Bil | |||
| Agilent Technologies Inc
A
| Qbhqwrnccq | Dsbh | $38.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Kwtxcsszhp | Rdtwc | $30.8 Bil | |||
| Icon PLC
ICLR
| Qbksztrz | Wflfjs | $26.5 Bil | |||
| Waters Corp
WAT
| Kltvlnmxq | Xnsbm | $17.8 Bil | |||
| Illumina Inc
ILMN
| Pqdrqwjz | Rcfsyn | $17.5 Bil | |||
| Labcorp Holdings Inc
LH
| Ftwxpmvcc | Hdpjl | $16.5 Bil |
